1-methyl-3-isobutylxanthine has been researched along with Pneumonia in 1 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
Pneumonia: Infection of the lung often accompanied by inflammation.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lee, CD | 1 |
Choi, WS | 1 |
Choi, YG | 1 |
Kang, HS | 1 |
Lee, WT | 1 |
Kim, HJ | 1 |
Lee, JY | 1 |
1 other study available for 1-methyl-3-isobutylxanthine and Pneumonia
Article | Year |
---|---|
Inhibition of phosphodiesterase suppresses allergic lung inflammation by regulating MCP-1 in an OVA-induced asthma murine model with co-exposure to lipopolysaccharide.
Topics: 1-Methyl-3-isobutylxanthine; Administration, Inhalation; Airway Resistance; Animals; Asthma; Broncho | 2020 |